Procter & Gamble Health Reports Strong Q2 Results with 26% PAT Growth
Procter & Gamble Health Ltd · Press Release · 02 Nov 2026, 8:23 pm
Procter & Gamble Health Reports Strong Q2 Results with 26% PAT Growth Procter & Gamble Health Ltd. reported robust Q2 financial results for the period ended 30th Sep'26. Sales rose 18% YoY to ₹376 crore, supported by strong brand fundamentals, improved retail execution, favorable consumer response to new innovations, and enhanced go-to-market execution. Reported Profit After Tax (PAT) climbed 26% YoY to ₹112 crore, driven by top-line expansion and sustained productivity gains across the value chain. Growth across key healthcare and VMS brands reflected rising consumer demand for preventive healthcare.
Original exchange filing (PDF)
More announcements from Procter & Gamble Health Ltd
- Stock Exchange is informed about an update on Ease of Investment - Special Window for Transfer and Dematerialization. · 17 Nov 2026
- Intimation for Change in Corporate Office address of Registrar and Share Transfer Agent (RTA) · 13 Nov 2026
- Outcome of Board Meeting for the Quarter Ended September 30, 2026 · 02 Nov 2026
- Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 02 Nov 2026
- Outcome of the Board Meeting for the Quarter and half year ended September 30 , 2026. · 02 Nov 2026
- PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 02 Nov 2026
- Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited financial .... · 02 Nov 2026
